Vasculitis & polymyalgia rheumatica

Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis

Arthritis Res TherPublished Diagnostic accuracy study

Authors' conclusion

The modified 2022 ACR/EULAR GCA classification criteria well performed in classifying GCA and TAK without PET-CT in routine clinical practice. A set of items included in the modified GCA classification criteria had good discriminative ability for GCA and TAK, even when age was excluded. However, age restriction or PMR was required to distinguish GCA without cranial lesions from TAK.

Study context

Population
Newly diagnosed patients with giant cell arteritis (GCA) or TAK enrolled in a Japanese nationwide retrospective registry
Participants
139 vs 129
Comparison
Modified 2022 ACR/EULAR GCA classification criteria (score ≥ 6) in GCA vs TAK as controls
  • GCAn = 139
  • TAKn = 129reference
Outcome
Discriminability of GCA from TAK by the modified 2022 ACR/EULAR GCA classification criteria (C-statistic; > 0.7: good ability)
Methodological detailsJapanese nationwide retrospective registry, modified criteria: aortic wall thickening by contrast-enhanced computed tomography (CT) or MRI instead of PET-CT
  • Japanese nationwide retrospective registry
  • Modified criteria: aortic wall thickening by contrast-enhanced CT or MRI instead of PET-CT

Performance

As reported in the abstract

C-statistic

0.986

95% CI 0.976–0.996

full criteria

C-statistic

0.927

95% CI 0.894–0.961

after excluding age

Further findings

Discriminability of the criteria after excluding age

C-statistic after excluding age (remained good)
0.927, 95% CI: 0.894-0.961
  • C-statistic > 0.7: good ability

Discriminability of item sets: large-vessel lesions (bilateral axillary artery and descending thoracic-abdominal aorta)

Large-vessel lesions + inflammatory markers: C-statistic (markedly decreased, poor)
0.598, 95% CI: 0.530-0.667
Large-vessel lesions + polymyalgia rheumatica (PMR): C-statistic (improved)
0.757, 95% CI: 0.700-0.813
Large-vessel lesions + age: C-statistic (improved)
0.913, 95%CI: 0.874-0.951

Late-onset TAK meeting the modified criteria

Late-onset TAK patients meeting the modified criteria
5
Of these, with cranial signs and symptoms
4
Of these, with bilateral axillary artery involvement
2
Of these, with descending thoracic-abdominal aorta involvement
4

Bilateral subclavian and/or axillary artery involvement in GCA with score ≤ 5

GCA with score ≤ 5 having bilateral subclavian and/or axillary artery involvement
52%

Original publication

Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis. Arthritis Res Ther. Published 31 January 2025. doi:10.1186/s13075-025-03486-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.